Voyageur Pharmaceuticals (TSXV:VM) Total Equity : C$1.58 Mil (As of Feb. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Total Equity?

Voyageur Pharmaceuticals's total equity for the quarter that ended in Feb. 2024 was C$1.58 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Voyageur Pharmaceuticals Total Equity Historical Data

The historical data trend for Voyageur Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Total Equity Chart

Voyageur Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Total Equity

Get a 7-Day Free Trial

0.75

0.31

1.91

1.47

1.44

Voyageur Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Equity	Get a 7-Day Free Trial															2.24	1.81	1.71	1.44	1.58

Voyageur Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Voyageur Pharmaceuticals's Total Equity for the fiscal year that ended in Nov. 2023 is calculated as

Total Equity	=	Total Assets(Q: Nov. 2023 )	-	Total Liabilities(Q: Nov. 2023 )
	=	2.164	-	0.728
	=	1.44

Voyageur Pharmaceuticals's Total Equity for the quarter that ended in Feb. 2024 is calculated as

Total Equity	=	Total Assets(Q: Feb. 2024 )	-	Total Liabilities(Q: Feb. 2024 )
	=	2.562	-	0.985
	=	1.58

Voyageur Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals (TSXV:VM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

VYYRF:USA

Address

333 Southwest 7th Avenue, Suite 800, Calgary, AB, CAN, T2P 2Z1

Website

https://www.voyageurpharmaceuticals.ca

Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine-based pharmaceutical products. It provides its products for medical applications and diagnostics.

Executives

Charles Littlejohn

10% Security Holder

Voyageur Pharmaceuticals (TSXV:VM) Headlines

No Headlines